Where Will OraSure Technologies, Inc. (OSUR) Stock Go Next After It Is Up 36.23% in a Week?

The market has been high on OraSure Technologies, Inc. (OSUR) stock recently. OSUR gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

OraSure Technologies, Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on OSUR!

See Full OSUR Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With OSUR Stock Today?

OraSure Technologies, Inc. (OSUR) stock is trading at $6.43 as of 2:40 PM on Monday, Aug 7, an increase of $0.49, or 8.25% from the previous closing price of $5.94. The stock has traded between $5.90 and $6.50 so far today. Volume today is more active than usual. So far 1,274,614 shares have traded compared to average volume of 569,082 shares.

More About OraSure Technologies, Inc.

OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States. Click Here to get the full Stock Report for OraSure Technologies, Inc. stock.